• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Open Forum Infect Dis . Transmission of SARS-CoV-2 Alpha Variant (B.1.1.7) From a BNT162b2-Vaccinated Individual

tetano

Editor, Senior Moderator
Open Forum Infect Dis


. 2021 Jul 20;8(8):ofab369.
doi: 10.1093/ofid/ofab369. eCollection 2021 Aug.
Transmission of SARS-CoV-2 Alpha Variant (B.1.1.7) From a BNT162b2-Vaccinated Individual


Solen Kernéis[SUP] 1 2 [/SUP], Delphine Planas[SUP] 3 4 [/SUP], Sandrine Imbeaud[SUP] 5 [/SUP], Isabelle Staropoli[SUP] 3 4 [/SUP], Julien Puech[SUP] 6 [/SUP], Nicolas Robillard[SUP] 6 [/SUP], Julien Rodary[SUP] 6 [/SUP], Timothée Bruel[SUP] 3 4 [/SUP], Thomas Vieillard[SUP] 7 [/SUP], Olivier Schwartz[SUP] 3 4 [/SUP], Laurent Belec[SUP] 6 8 9 [/SUP], Hélène Péré[SUP] 5 [/SUP], David Veyer[SUP] 5 6 [/SUP]



Affiliations

Abstract

Cases of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) acquisition after vaccination with BNT162b2 have been described, but the risk of secondary transmission from fully vaccinated individuals remains ill defined. Herein we report a confirmed transmission of SARS-CoV-2 alpha variant (B.1.1.7) from a symptomatic immunocompetent woman 4 weeks after her second dose of BNT162b2, despite antispike seroconversion.

Keywords: BNT162b2; SARS-CoV-2; transmission; vaccination.
 
Back
Top Bottom